Kuala Lumpur - Delayed Quote MYR

Southern Acids (M) Berhad (5134.KL)

3.2400
+0.0200
+(0.62%)
At close: May 9 at 12:23:19 PM GMT+8

Key Executives

Amounts are as of December 31, 2024 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in MYR.
NameTitlePayExercisedYear Born
Dr. Kok Thye Low MD & Non-Independent Executive Director 941.88k -- 1979
Mr. Kim Long Lim Non-Independent Executive Director 759.05k -- 1960
Mr. Kee Yoong Cheong Chief Financial Officer -- -- 1968
Mr. Thevakumar Kaliaperumal General Manager of Operations, Milling & Cultivation -- -- 1971
Mr. Chuu Ling Tiong Chief Operating Officer of Oleochemical Manufacturing Segment -- -- 1953
Mr. Choon Hoong Chan Chief Strategic Development Officer -- -- 1972
Ms. Kui Suang Lim FCIS Company Secretary -- -- --
Shu Ling Ng Company Secretary -- -- --

Southern Acids (M) Berhad

Centro Tower
Level 29 No. 8, Jalan Batu Tiga Lama
Klang, 41300
Malaysia
60 3 3258 3333 https://www.southernacids.com
Sector: 
Industrials
Industry: 
Conglomerates
Full Time Employees: 
1,745

Description

Southern Acids (M) Berhad, an investment holding company, engages in the manufacture and marketing of oleochemical products. The company operates through three segments: Oleochemical Manufacturing, Milling & Cultivation, and Healthcare Services. It manufactures and markets fatty acids and glycerine for use in various applications, including personal care, cleaning agents, and food products. The company is also involved in the processing of fresh fruit bunches into crude palm oil and palm kernel, as well as oil palm cultivation activities. In addition, it operates a 232-bedded private tertiary hospital in Klang for the provision of cardiology, hand and microsurgery, nephrology, neurosurgery, orthopaedic surgery, obstetrics and gynaecology, radiotherapy, and oncology services, as well as E.N.T., head and neck surgery, hand and microsurgery, nephrology, neurology, orthopaedic surgery, obstetrics and gynaecology, and radiotheraphy and oncology services. Further, the company provides administrative and accounting, and overhead conveyor goods loading services; and develops properties and leases hospital building. It operates in Malaysia, Indonesia, rest of Asia, Europe, the United States, and internationally. Southern Acids (M) Berhad was incorporated in 1980 and is headquartered in Klang, Malaysia.

Corporate Governance

Southern Acids (M) Berhad’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

Recent Events

October 17, 2024 at 12:00 AM UTC

Ex-Dividend Date

Related Tickers